Basket Trials: Just the End of the First Quarter

Affiliations

¹ University Hospital Heidelberg, and National Center for Tumor Diseases, Heidelberg, Germany albrecht.stenzinger@med.uni-heidelberg.de.
² University Hospital Heidelberg, National Center for Tumor Diseases, and German Cancer Consortium, Heidelberg, Germany.
³ Massachusetts General Hospital/Harvard Medical School, Boston, MA.
⁴ Charité University Hospital; Einstein Foundation, Berlin, Germany.

Comment

Albrecht Stenzinger et al. J Clin Oncol. 2015.

. 2015 Sep 1;33(25):2823-4.

doi: 10.1200/JCO.2015.62.1516. Epub 2015 Jul 13.

¹ University Hospital Heidelberg, and National Center for Tumor Diseases, Heidelberg, Germany albrecht.stenzinger@med.uni-heidelberg.de.
² University Hospital Heidelberg, National Center for Tumor Diseases, and German Cancer Consortium, Heidelberg, Germany.
³ Massachusetts General Hospital/Harvard Medical School, Boston, MA.
⁴ Charité University Hospital; Einstein Foundation, Berlin, Germany.

No abstract available

Comment in

Reply to A. Stenzinger et al.
Thomas A, Lopez-Chavez A, Giaccone G. Thomas A, et al. J Clin Oncol. 2015 Sep 1;33(25):2824. doi: 10.1200/JCO.2015.62.7323. Epub 2015 Jul 13. J Clin Oncol. 2015. PMID: 26169619 No abstract available.

Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial.
Lopez-Chavez A, Thomas A, Rajan A, Raffeld M, Morrow B, Kelly R, Carter CA, Guha U, Killian K, Lau CC, Abdullaev Z, Xi L, Pack S, Meltzer PS, Corless CL, Sandler A, Beadling C, Warrick A, Liewehr DJ, Steinberg SM, Berman A, Doyle A, Szabo E, Wang Y, Giaccone G. Lopez-Chavez A, et al. J Clin Oncol. 2015 Mar 20;33(9):1000-7. doi: 10.1200/JCO.2014.58.2007. Epub 2015 Feb 9. J Clin Oncol. 2015. PMID: 25667274 Free PMC article. Clinical Trial.